KGK Science Inc.

Psychedelics company Wellbeing Digital Sciences Inc. (OTC: KONEF)’s subsidiary KGK Science Inc. has entered into a research services agreement with Canadian-based biotech Nova Mentis Life Science Corp. (OTC: NMLSF) for a first-of-its-kind Phase 2 clinical trial on psilocybin microdoses...

Wellbeing Digital Sciences Inc. (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company announced that its wholly-owned subsidiary KGK Science Inc. completed an open-label study, where Gefion Canada  GT4 technology was used to successfully deliver...